Proteins 79 (Suppl 10), 161171 (2011)

Amylin/Calcitonin Receptor Agonism (cagrilintide) Delays gastric emptying, reduces postprandial glucagon, and strongly promotes satiety Modulates appetite-regulating centers in the hindbrain, hypothalamus, and brain reward circuits, directly influencing food intake and choice May transiently activate the renin-angiotensin-aldosterone system with dose escalation, but without blood pressure or electrolyte derangements GLP-1 Receptor Agonism (semaglutide) Stimulates glucose-dependent insulin secretion and suppresses glucagon release to improve glycemic control Reduces appetite and ad libitum energy intake, with central effects on GLP-1R-expressing nuclei in hypothalamus and brainstem Delays gastric emptying and increases satiety, contributing to progressive bodyweight loss Pharmacokinetic Profile Route of Administration Subcutaneous Dosing Frequency Once weekly Route of Administration : Subcutaneous Injection Dosing Frequency: Once weekly Half -life: Cagrilintide: 7-8 days

Acetylcholine is a main brain neurotransmitter through which the brain cells talk to each other
The unmatched longevity benefits of exercise, its synergy with higher protein intake, and Peters recommended protein intake [A: 1:06:15, V: 1:11:33]
Most experts suggest staying consistent with glutathione capsules for at least 90 days, because glutathione works gradually and the body needs time to build and maintain healthy levels
Both ALCAR and L-Carnitine support the transport of long-chain fatty acids into mitochondria contributing to energy production